Clinical trial

VACcination In Methotrexate Treated Rheumatoid Arthritis Patients

NCT01942174

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-09-27

PhasePHASE3

Study timeline

Study start (actual)2013-09-27Date precision: day

Registry last updated2020-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Prevenar 13BIOLOGICAL

Pneumo23 / PneumovaxBIOLOGICAL

Methotrexate - ImmediateDRUG

Methotrexate - DelayDRUG

Sponsors & collaborators

University Hospital, Montpellierlead sponsor

Hôpital Cochincollaborator

Pfizercollaborator

Mapped research locations

ParisFrance2 ToulouseFrance1 MarseilleFrance1 MontpellierFrance1 StrasbourgFrance1 BordeauxFrance1 RennesFrance1 NiceFrance1 Clermont-FerrandFrance1 RouenFrance1 BrestFrance1 ToursFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01942174 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.